US regulatory developments on PFOA   As early as2000, 3M announced the phase-out of the production of PFOA, PFOS, and PFOS-related products.The chemical has received attention due to the litigation against DuPont, resulting in a settlement of $235 million. The EPA has not officially classified PFOA as to its carcinogenicity, but EPA has been investigating PFOA because it;       -  Is very persistent in the environment       -  Is found at low levels both in the environment and in the blood of the general          U.S.population       -  Remains in people for a very long time, and       -  Causes developmental and other adverse effects in laboratory animals. In 2006, EPA and the eight major companies in the industry launched the 2010/15 PFOA Stewardship Program, in which companies committed to reduce global facility emissions and product content of PFOA and related chemicals by 95 percent by 2010, and to work toward eliminating emissions and product content by 2015.Participating companies include: Arkema, Asahi, BASF Corporation (successor to Ciba), Clariant, Daikin, 3M/Dyneon, DuPont, Solvay Solexis. In January 2015, EPA released the most recent report for 2014 from participating companies on progress in reaching the program’s phase-out goals. Results show that the companies are on track to reach the program’s goal of phasing out these chemicals by the end of 2015. EPA is proposing to amend a significant new use rule (SNUR) for long-chain perfluoroalkyl carboxylate (LCPFAC) chemical substances by designating it as a significant new use manufacturing for any use that will not be ongoing after December 31, 2015, and all others for which there are currently no ongoing uses. EPA will not designate currently ongoing uses as significant new uses, except for uses that will be phased out by the end of 2015. PFOA and its salts are subject to this proposed rule. EPA believes all significant uses of PFOA and its salts were phased out by December 31, 2013. In August 2014, the Centers for Disease Control and Prevention reported a 41 percent reduction of PFOA in human blood from 1999 ? 2010. This decline is largely attributed to EPA's efforts on perfluorinated chemicals. For further reading, Click here for definition of PFOA. Click here for regulatory status in limiting the commercial use of PFOA in Europe. Click here for Luvantix ADM’s PFOA free products. Frequent Questions on PFOA and Fluorinated Telomers